Log in
Enquire now
‌

US Patent 11473123 Morphinan compounds

Patent 11473123 was granted and assigned to Concert Pharmaceuticals on October, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Concert Pharmaceuticals
Concert Pharmaceuticals
0
Current Assignee
Concert Pharmaceuticals
Concert Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114731230
Patent Inventor Names
Roger Tung0
Date of Patent
October 18, 2022
0
Patent Application Number
171208800
Date Filed
December 14, 2020
0
Patent Primary Examiner
‌
Charanjit Aulakh
0
CPC Code
‌
A61K 31/439
0
‌
A61P 25/00
0
‌
A61P 35/00
0
‌
A61K 31/4748
0

This disclosure relates to novel morphinan compounds and their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a σ

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11473123 Morphinan compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.